Characterization of breast cancer by array comparative genomic hybridization

Biochemistry and Cell Biology

Volumn 85, Issue 4, 2007, Pages 497-508

  Climent, J ^a   Garcia, J L ^b   Mao, J H ^a   Arsuaga, J ^c   Perez Losada, J ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Centro de Investigacion del Cancer   (Spain)

^c SAN FRANCISCO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Breast cancer; Chromosome aberrations; Comparative genomic hybridization arrays

Indexed keywords

BIOASSAY; BIOINFORMATICS; CHARACTERIZATION; GENES; PATIENT MONITORING; TUMORS;

BREAST CANCER; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION ARRAYS; GENOMIC ALTERATIONS; TUMOR SUPPRESSOR GENES;

ONCOLOGY;

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR;

BIOINFORMATICS; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER SUSCEPTIBILITY; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; ONCOGENE; PROGNOSIS; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; CYTOGENETIC ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 34948833281     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O07-072     Document Type: Short Survey

References (135)

1. Albertson, D.G., and Pinkel, D. 2003. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 2: R145-152.
2. Albertson, D.G., Collins, C., McCormick, F., and Gray, J.W. 2003. Chromosome aberrations in solid tumors. Nat. Genet. 34: 369-376. doi:10.1038/ng1215.
3. Alvarez, S., Diaz-Uriarte, R., Osorio, A., Barroso, A., Melchor, L., Paz, M.F., et al. 2005. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin. Cancer Res. 11: 1146-1153.
4. Aubele, M., Cummings, M., Walsch, A., Zitzelsberger, H., Nahrig, J., Hofler, H., and Werner, M. 2000. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Anal. Cell. Pathol. 20: 17-24.
5. Aubele, M., Auer, G., Braselmann, H., Nahrig, J., Zitzelsberger, H., Quintanilla-Martinez, L., et al. 2002. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal. Cell. Pathol. 24: 77-87.
6. Ayers, M., Symmans, W.F., Stec, J., Damokosh, A.I., Clark, E., Hess, K., et al. 2004. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin., and cyclophosphamide chemotherapy in breast cancer. J. Clin. Oncol. 22: 2284-2293. doi:10.1200/JCO.2004.05.166.
7. Balmain, A. 2002. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell, 108: 145-152. doi:10.1016/S0092- 8674(02)00622-0.
8. Balmain, A., Gray, J., and Ponder, B. 2003. The genetics and genomics of cancer. Nat. Genet. 33 (Suppl.): 238-244. doi:10.1038/ng1107.
9. Barber, J.C., Joyce, C.A., Collinson, M.N., Nicholson, J.C., Willatt, L.R., Dyson, H.M., et al. 1998. Duplication of 8p23.1: a cytogenetic anomaly with no established clinical significance. J. Med. Genet. 35: 491-496.
10. Bärlund, M., Monni, O., Weaver, J.D., Kauraniemi, P., Sauter, G., Heiskanen, M., Kallioniemi, O.P., and Kallioniemi, A. 2002. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer, 35: 311-317. doi:10.1002/gcc.10121.
11. Boecker, W., Buerger, H., Schmitz, K., Ellis, I.A., van Diest, P.J., Sinn, H.P., et al. 2001. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular- weight cytokeratin expression patterns. J. Pathol. 195: 415-421. doi:10.1002/path.982.
12. Broet, P., and Richardson, S. 2006. Detection of gene copy number changes in CGH microarrays using a spatially correlated mixture model. Bioinformatics, 22: 911-918. doi:10.1093/bioinformatics/bt1035.
13. Buerger, H., Otterbach, F., Simon, R., Poremba, C., Diallo, R., Decker, T., et al. 1999. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J. Pathol. 187: 396-402. doi:10.1002/(SICI) 1096-9896(199903)187:4〈396::AID-PATH286〉3. 0.CO;2-L.
14. Buerger, H., Mommers, E.C., Littmann, R., Simon, R., Diallo, R., Poremba, C., et al. 2001. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J. Pathol. 194: 165-170. doi:10.1002/path.875.
15. Burstein, H.J., Polyak, K., Wong, J.S., Lester, S.C., and Kaelin, C.M. 2004. Ductal carcinoma in situ of the breast. N. Engl. J. Med. 350: 1430-1441. doi:10.1056/NEJMra031301.
16. Callagy, G., Pharoah, P., Chin, S.F., Sangan, T., Daigo, Y., Jackson, L., and Caldas, C 2005. Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J. Pathol. 205: 388-396. doi:10.1002/path.1694.
17. Carter, S.L., Eklund, A.C., Kohane, i.S., Harris, L.N., and Szallasi, Z. 2006. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38: 1043-1048. doi:10.1038/ng1861.
18. Chang, J.C., Wooten, E.C., Tsimelzon, A., Hilsenbeck, S.G., Gutierrez, M.C., Elledg, R., et al. 2003. Gene expression profiling for the prediction of therapeutic response todocetaxel in patients with breast cancer. Lancet, 362: 362-369. doi:10.1016/S0140-6736(03)14023-8.
19. Chen, W., Erdogan, F., Ropers, H.H., Lenzner, S., and Ullmann, R. 2005. CGHPRO, a comprehensive data analysis tool for array CGH. BMC Bioinformatics, 56: 85.
20. Cheng, K.W., Lahad, J.P., Kuo, W.L., Lapuk, A., Yamada, K., Auersperg, N., et al. 2004. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10: 1251-1256. doi:10.1038/nm1125.
21. Chin, K., DeVries, S., Fridlyand, J., Spellman, P.T., Roydasgupta, R., Kuo, W.L., et al. 2006. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell, 10: 529-541. doi:10.1016/j.ccr. 2006.10.009.
22. Cingoz, S., Altungoz, O., Canda, T., Saydam, S., Aksakoglu, G., and Sakizli, M. 2003. DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors. Cancer Genet. Cytogenet. 145: 108-114. doi:10.1016/S0165-4608(03) 00094-3.
23. Clarke, C.A., Glaser, S.L., West, D.W., Ereman, R.R., Erdmann, C.A., Barlow, J.M., and Wrensch, M.R. 2002. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, U.S.A., 1990-1999. Breast Cancer Res. 4: R13. doi:10.1186/bcr458.
24. Cleton-Jansen, A.M. 2002. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res. 4: 5-8. doi:10.1186/bcr416.
25. Cleton-Jansen, A.M., Buerger, H., Haar, N., Philippo, K., van de Vijver, M.J., Boecker, W., Smit, V.T., and Cornelisse, C.J. 2004. Different mechanisms of chromosome 16 loss of heterozygosity in well versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer, 41: 109-116. doi:10.1002/gcc.20070.
26. Climent, J., Martinez-Climent, J.A., Blesa, D., Garcia-Barchino, M.J., Saez, R., Sanchez-Izquierdo, D., et al. 2002. Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer. Clin. Cancer Res. 8: 3863-3869.
27. Climent, J., Dimitrow, P., Fridlyand, J., Palacios, J., Siebert, R., Albertson, D.G., et al. 2007. Deletion of chromosome Hq predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res. 67: 818-826. doi:10.1158/0008-5472.CAN-06-3307.
28. Cowell, J.K., LaDuca, J., Rossi, M.R., Burkhardt, T., Nowak, N.J., and Matsui, S. 2005. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet. Cytogenet. 163: 23-29. doi:10.1016/j.cancergencyto.2005.04.019.
29. Cox, C., Bignell, G., Greenman, C., Stabenau, A., Warren, W., Stephens, P., et al. 2005. A survey of homozygous deletions in human cancer genomes. Proc. Natl. Acad. Sci. U.S.A. 102: 4542-4547. doi:10.1073/pnas.0408593102.
30. Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H., Busam, K., Kutzner, H., et al. 2005. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353: 2135-2147. doi:10.1056/NEJMoa050092.
31. Damiani, S., Dina, R., and Eusebi, V. 1999. Eosinophilic and granular cell tumors of the breast. Semin. Diagn. Pathol. 16: 117-125.
32. Darawala, R.S., Rudra, A., Ostrer, H., Lucito, R., Wigler, M., and Mishra, B. 2004. A versatile statistical analysis algorithm to detect genome copy number variation. Proc. Natl. Acad. Sci. U.S.A. 101: 16292-16297. doi:10.1073/pnas.0407247101.
33. Dhami, P., Coffey, A.J., Abbs, S., Vermeesch, J.R., Dumanski, J.P., Woodward, K.J., et al. 2005. Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome. Am. J. Hum. Genet. 76: 750-762. doi:10.1086/429588.
34. Delias, A., Torhorst, J., Schultheiss, E., Mihatsch, M.J., and Moch, H. 2002. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. Clin. Cancer Res. 8: 1210-1216.
35. Diallo, R., Schaefer, K.L., Bankfalvi, A., Decker, T., Ruhnke, M., Wulfing, P., et al. 2003. Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry. Hum. Pathol. 34: 1299-1305. doi:10.1016/S0046- 8177(03)00423-4.
36. Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., and Hart, I.R. 2001. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer, 92: 404-408. doi:10.1002/ijc.1208.
37. Eilers, P.H., and de Menezes, R.X. 2005. Quantile smoothing of array CGH data. Bioinformatics, 21: 1146-1153.
38. Engelen, J.J., Moog, U., Evers, J.L., Dassen, H., Albrechts, J.C., and Hamers, A.J. 2000. Duplication of chromosome region 8p23.1→p23.3: a benign variant? Am. J. Med. Genet. 91: 18-21. doi:10.1002/(SICI)1096- 8628(20000306)91:1〈18::AID-AJMG3〉3.0.CO;2-3.
39. Ewart-Toland, A., Briassouli, P., de Koning, J.P., Mao, J.H., Yuan, J., Chan, F., et al. 2003. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat. Genet. 34: 403-12. doi:10.1038/ng1220.
40. Freedman, M.L., Reich, D., Penney, K.L., McDonald, G.J., Mignault, A.A., Patterson, N., et al. 2004. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36: 388-393. doi:10.1038/ng1333.
41. Fridlyand, J., Snijders, A., Pinkel, D., Albertson, D.G., and Jain, A. 2004. Application of Hidden Markov models to the analysis of the array CGH data. J. Multivariate Anal. 90: 132-153. doi:10.1016/j.jmva.2004.02.008.
42. Fridlyand, J., Snijders, A.M., Ylstra, B., Li, H., Olshen, A., Segraves, R., et al. 2006. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer, 6: 96. . doi:10.1186/1471-2407-6-96.
43. Fung, L.F., Wong, N., Tang, N., Lau, A., Wong, V., Pang, C.P., et al. 2001. Genetic imbalances in pT2 breast cancers of southern Chinese women. Cancer Genet. Cytogenet. 124: 56-61. doi:10.1016/S0165-4608(00)00328-9.
44. Garcia, M.J., Pole, J.C., Chin, S.F., Teschendorff, A., Naderi, A., Ozdag, H., et al. 2005. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene, 24: 5235-5245. doi:10.1038/sj.onc.1208741.
45. Goldgar, D.E., Easton, D.F., Cannon-Albright, L.A., and Skolnick, M.H. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86: 1600-1608. doi:10.1093/jnci/86.21.1600.
46. Günther, K., Merkelbach-Brase, S., Amo-Takyi, B.K., Handt, S., Schroder, W., and Tietze, L. 2001. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. J. Pathol. 193: 40-47. doi:10.1002/1096-9896(2000)9999: 9999〈::AID-PATH745〉3.0. CO;2-N.
47. Hanahan, D., and Weinberg, R.A. 2000. The hallmarks of cancer. Cell, 100: 57-70. doi:10.1016/S0092-8674(00)81683-9.
48. Heidenblad, M., Lindgren, D., Veltman, J.A., Jonson, T., Mahlamaki, E.H., Gorunova, L., et al. 2005. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene, 24: 1794-1801. doi:10.1038/sj.onc.1208383.
49. Hermsen, M.A., Baak, J.P., Meijer, G.A., Weiss, J.M., Walboomers, J.W., Snijders, P.J., and van Diest, P.J. 1998. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J. Pathol. 186: 356-362. doi:10.1002/(SICI)1096-9896(199812)186:4〈356::AID-PATH196〉3. 0.CO;2-Z.
50. Hislop, R.G., Pratt, N., Stocks, S.C., Steel, C.M., Sales, M., Goudie, D., Robertson, A., and Thompson, A.M. 2002. Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br. J. Surg. 89: 1581-1586. doi:10.1046/j.1365-2168.2002.02270.x.
51. Huang, T., Wu, B., Lizardi, P., and Zhao, H. 2005. Detection of DNA copy number alterations using penalized least squares regression. Bioinformatics, 21: 3811-3817. doi:10.1093/bioinformatics/bti646.
52. Hupe, P., Stransky, N., Thiery, J.P., Radvanyi, F., and Barillot, E. 2004. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics, 20: 3413-3422. doi:10.1093/bioinformatics/ bth418.
53. Hyman, E., Kauraniemi, P., Hautaniemi, S., Wolf, M., Mousses, S., Rozenblum, E., et al. 2002. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62: 6240-6245.
54. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe, P.K., Qi, Y., Scherer, S.W., and Lee, C. 2004. Detection of large-scale variation in the human genome. Nat. Genet. 36: 949-951. doi:10.1038/ng1416.
55. Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., and Contopoulos- Ioannidis, D.G. 2001. Replication validity of genetic association studies. Nat. Genet. 29: 306-309. doi:10.1038/ng749.
56. Isola, J.J., Kallioniemi, O.P., Chu, L.W., Fuqua, S.A., Hilsenbeck, S.G., Osborne, C.K., and Waldman, F.M. 1995. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol. 147: 905-911.
57. Janssen, E.A., Baak, J.P., Guervos, M.A., van Diest, P.J., Jiwa, M., and Hermsen, M.A. 2003. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated, with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. J. Pathol. 201: 555-561. doi:10.1002/path.1475.
58. Jones, C., Foschini, M.P., Chaggar, R., Lu, Y.J., Wells, D., Shipley, J.M., Eusebi, V., and Lakhani, S.R. 2000. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab. Invest. 80: 831-836.
59. Jones, C., Ford, E., Gillett, C., Ryder, K., Merrett, S., Reis-Filho, J.S., et al. 2004. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin. Cancer Res. 10: 5988-5997. doi:10.1158/1078-0432.CCR-03-0731.
60. Jong, K., Marchiori, E., Meijer, G., Vaart, A.V., and Ylstra, B. 2004. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics, 20: 3636-3637. doi:10.1093/ bioinformatics/bth355.
61. Jonsson, G., Naylor, T.L., Vallon-Christersson, J., Staaf, J., Huang, J., Ward, M.R., et al. 2005. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res. 65: 7612-7621.
62. Kallioniemi, A., Kallioniemi, O.P., Sudar, D., Rutovitz, D., Gray, J.W., Waldman, F., and Pinkel, D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258: 818-821. doi:10.1126/science.1359641.
63. Kallioniemi, O.P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F.M., Gray, J.W., and Pinkel, D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer, 10: 231-243. doi:10.1002/gcc.2870100403.
64. Khojasteh, M., Lam, W.L., Ward, R.K., and MacAulay, C. 2005. A stepwise framework for the normalization of array CGH data. BMC Bioinformatics, 6: 274. doi:10.1186/1471-2105-6-274.
65. Kirchhoff, M., Gerdes, T., Rose, H., Maahr, J., Ottesen, A.M., and Lundsteen, C. 1998. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry, 31: 163-173. doi:10.1002/(SICI)1097-0320(19980301)31:3〈163::AID- CYTO3〉3.0.CO;2-M.
66. Kirchhoff, M., Gerdes, T., Maahr, J., Rose, H., Bentz, M., Dahner, H., and Lundsteen, C. 1999. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer, 25: 410-413. doi:10.1002/(SICI)1098-2264(199908)25: 4〈410::AID-GCC17〉3.0.CO;2-J.
67. Knutsen, T., Gobu, V., Knaus, R., Padilla-Nash, H., Augustus, M., Strausberg, R.L., et al. 2005. The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer, 44: 52-64. doi:10.1002/gcc.20224.
68. Korsching, E., Packeisen, J., Agelopoulos, K., Eisenacher, M., Voss, R., Isola, J., et al. 2002. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab. Invest. 82: 1525-1533.
69. Korsching, E., Packeisen, J., Helms, M.W., Kersting, C., Voss, R., van Diest, P.J., et al. 2004. Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br. J. Cancer, 90: 1422-1428. doi:10.1038/sj.bjc.6601658.
70. Lakhani, S.R. 2003. In-situ lobular neoplasia: time for an awakening. Lancet, 361: 96. doi:10.1016/S0140-6736(03)12240-4.
71. Lakhani, S.R., Slack, D.N., Hamoudi, R.A., Collins, N., Stratton, M.R., and Sloane, J.P. 1996. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab. Invest. 74: 129-135.
72. La Rosa, P., Viara, E., Hupe, P., Pierron, G., Liva, S., Neuvial, P., et al. 2006. VAMP: visualization and analysis of array-CGH, transcriptome and other molecularprofiles. Bioinformatics, 22: 2066-2073. doi:10.1093/ bioinformatics/bt1359.
73. Le Voyer, T., Lu, Z., Babb, J., Lifsted, T., Williams, M., and Hunter, K. 2000. An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm. Genome, 11: 883-889. doi:10.1007/s003350010163.
74. Lin, H., Pizer, E.S., and Morin, P.J. 2000. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer. Genomics, 69: 391-394. doi:10.1006/geno.2000. 6357.
75. Lingjaerde, O.C., Baumbusch, L.O., Liestol, K., Glad, I.K., and Borresen-Dale, A.L. 2005. CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics, 21: 821-822.
76. Liva, S., Hupé, P., Neuvial, P., Brito, I., Viara, E., La Rosa, P., and Barillot, E. 2006. CAPweb: a bioinformatics CGH array analysis platform. Nucleic Acids Res. 34: W477-481. doi:10.1093/nar/gkl215.
77. Loveday, R.L., Greenman, J., Simcox, D.L., Speirs, V., Drew, P.J., Monson, J.R., and Kerin, M.J. 2000. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int. J. Cancer, 86: 494-500. doi:10.1002/(SICI)1097-0215(20000515)86:4〈494::AID-IJC8〉3.0.CO;2-O.
78. Lu, Y.J., Osin, P., Lakhani, S.R., Di Palma, S., Gusterson, B.A., and Shipley, J.M. 1998. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 58: 4721-4727.
79. Mao, J.H., Perez-Losada, J., Wu, D., Delrosario, R., Tsunematsu, R., Nakayama, K.I., et al. 2004. Fbxw7/Cdc4 is a p53-dependent., haploinsufficient tumour suppressor gene. Nature, 432: 775-779. doi:10.1038/nature03155.
80. Martinez-Climent, J.A., Alizadeh, A.A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D.G., et al. 2003. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood, 101: 3109-3117. doi:10.1182/blood-2002-07-2119.
81. Menten, B., Pattyn, F., De Preter, K., Robbrecht, P., Michels, E., Buysse, K., et al. 2005. ArrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics, 6: 124. doi:10.1186/1471-2105-6-124.
82. Morabito, A., Magnani, E., Gion, M., Sarmiento, R., Capaccetti, B., Longo, R., Gattuso, D., and Gasparini, G. 2003. Prognostic and predictive indicators in operable breast cancer. Clin. Breast Cancer, 3: 381-390.
83. Nessling, M., Richter, K., Schwaenen, C., Roerig, P., Wrqbel, G., Wessendorf, S., et al. 2005. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res. 65: 439447.
84. Neuvial, P., Hupé, P., Brito, I., Liva, S., Manié, E., Brennetot, C., et al. 2006. Spatial normalization of array-CGH data. BMC Bioinformatics, 7: 264. doi:10.1186/1471-2105-7-264.
85. Nishizaki, T., Chew, K., Chu, L., Isola, J., Kallioniemi, A., Weidner, N., and Waldman, F.M. 1997. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int. J. Cancer, 74: 513-517. doi:10.1002/(SICI)1097-0215(19971021) 74:5〈513::AID-IJC6〉3.0.CO;2-6.
86. Nyante, S.J., Devries, S., Chen, Y.Y., and Hwang, E.S. 2004. Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum. Pathol. 35: 759-763. doi:10.1016/j.humpath. 2003.11.009.
87. Osin, P., Lu, Y.J., Stone, J., Crook, T., Houlston, R.S., Gasco, M., Gusterson, B.A., and Shipley, J. 2003. Distinct genetic and epigenetic changes in medullary breast cancer. Int. J. Surg. Pathol. 11: 153-158.
88. Packeisen, J., Nakachi, K., Boecker, W., Brandt, B., and Buerger, H. 2005. Cytogenetic differences in breast cancer samples between German and Japanese patients. J. Clin. Pathol. 58: 1101-1103. doi:10.1136/jcp.2004. 022392.
89. Palacios, J., Sarrio, D., Garcia-Macias, M.C., Bryant, B., Sobel, M.E., and Merino, M.J. 2003. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod. Pathol. 16: 674-678. doi:10.1097/01.MP.0000073974.42583.F7.
90. Paris, P.L., Andaya, A., Fridlyand, J., Jain, A.N., Weinberg, V., Kowbel, D., et al. 2004. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum. Mol. Genet. 13: 1303-1313. doi:10.1093/hmg/ddh155.
91. Perou, C.M., Sarlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., et al. 2000. Molecular portraits of human breast tumours. Nature, 406: 747-752. doi:10.1038/35021093.
92. Picard, F., Robin, S., Lavielle, M., Vaisse, C., and Daudin, J.J. 2005. A statistical approach for array CGH data analysis. BMC Bioinformatics, 6: 27. doi:10.1186/1471-2105-6-27.
93. Pinkel, D., and Albertson, D.G. 2005a. Array comparative genomic hybridization and its applications in cancer. Nat. Genet. 37 (Suppl.): S11-S17. doi:10.1038/ng1569.
94. Pinkel, D., and Albertson, D.G. 20056. Comparative genomic hybridization. Annu. Rev. Genomics Hum. Genet. 6: 331-354. doi:10.1146/annurev.genom.6. 080604.162140.
95. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., et al. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20: 207-211. .] doi:10.1038/2524.
96. Pollack, J.R., Perou, C.M., Alizadeh, A.A., Eisen, M.B., Pergamenschikov, A., Williams, C.F., et al. 1999. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23: 41-46.
97. Pollack, J.R., Sorlie, T., Perou, C.M., Rees, C.A., Jeffrey, S.S., Lonning, P.E., et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. U.S.A. 99: 12963-12968. doi:10.1073/pnas.162471999.
98. Polyak, K. 2002. Breast cancer gene discovery. Expert Rev. Mol. Med. 2002: 1-18.
99. Prentice, L.M., Shadeo, A., Lestou, V.S., Miller, M.A., deLeeuw, R.J., Makretsov, N., et al. 2005. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene, 24: 7281-7289. doi:10.1038/sj.onc.1208892.
100. Press, M.F., Slamon, D.J., Flom, K.J., Park, J., Zhou, J.Y., and Bernstein, L. 2002. Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J. Clin. Oncol. 20: 3095-3105.
101. Rakha, E.A., Pinder, S.E., Paish, C.E., and Ellis, I.O. 2004. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1. Br. J. Cancer, 91: 1591-1596. doi:10.1038/sj.bjc. 6602144.
102. Ray, M.E., Yang, Z.Q., Albertson, D., Kleer, C.G., Washburn, J.G., Macoska, J.A., and Ethier, S.P. 2004. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 64: 40-47. doi:10.1158/0008-5472.CAN-03-1022.
103. Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., et al. 2006. Global variation in copy number in the human genome. Nature, 444: 444-454. doi:10.1038/nature05329.
104. Reis-Filho, J.S., and Lakhani, S.R. 2003. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res. 5: 313-319. doi:10.1186/bcr650.
105. Reis-Filho, J.S., Fulford, L.G., Freeman, A., and Lakhani, S.R. 2003. Pathologic quiz case: a 93-year-old woman with an enlarged and tender left breast. Histiocytoid variant of lobular breast carcinoma. Arch. Pathol. Lab. Med. 127: 1626-1628.
106. Reis-Filho, J.S., Simpson, P.T., Gale, T., and Lakhani, S.R. 2005. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol. Res. Pract. 201: 713-725.
107. Richard, F., Pacyna-Gengelbach, M., Schluns, K., Fleige, B., Winzer, K.J., Szymas, J., et al. 2000. Patterns of chromosomal imbalances in invasive breast cancer. Int. J. Cancer, 89: 305-310. doi:10.1002/1097- 0215(20000520)89:3〈305::AID-IJC15〉3.0. CO;2-8.
108. Roylance, R., Gorman, P., Harris, W., Liebmann, R., Barnes, D., Hanby, A., and Sheer, D. 1999. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59: 1433-1436.
109. Roylance, R., Droufakou, S., Gorman, P., Gillett, C., Hart, I.R., Hanby, A., and Tomlinson, I. 2003. The role of E-cadherin in low-grade ductal breast tumourigenesis. J. Pathol. 200: 53-58. doi:10.1002/path.1326.
110. Rubio-Moscardo, F., Climent, J., Siebert, R., Piris, M.A., Martin-Subero, J.I., Nielander, I., et al. 2005. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood, 105: 4445-4454. doi:10.1182/blood-2004-10-3907.
111. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., et al. 2004. Large-scale copy number polymorphism in the human genome. Science, 305: 525-528. doi:10.1126/science.1098918.
112. Selim, A.G., Ryan, A., El-Ayat, G., and Wells, C.A. 2002. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis. J. Pathol. 196: 287-291. doi:10.1002/path.1043.
113. Seute, A., Sinn, H.P., Schlenk, R.F., Emig, R., Wallwiener, D., Grischke, E.M., et al. 2001. Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int. J. Cancer, 93: 80-84. doi:10.1002/ijc.1296.
114. Shelley Hwang, E., Nyante, S.J., Yi Chen, Y., Moore, D., DeVries, S., Korkola, J.E., Esserman, L.J., and Waldman, F.M. 2004. Clonality of lobular carcinoma in situ and synchronous invasive lobular Carcinoma. Cancer, 100: 2562-2572. doi:10.1002/cncr.20273.
115. Simpson, P.T., Gale, T., Fulford, L.G., Reis-Filho, J.S., and Lakhani, S.R. 2003. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 5: 258-262. doi:10.1186/bcr624.
116. Simpson, P.T., Reis-Filho, J.S., Gale, T., and Lakhani, S.R. 2005. Molecular evolution of breast cancer. J. Pathol. 205: 248-254. doi:10.1002/path.1691.
117. Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A. 98: 10869-10874. doi:10.1073/pnas.191367098.
118. Thor, A.D., Eng, C., Devries, S., Paterakos, M., Watkin, W.G., Edgerton, S., et al. 2002. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum. Pathol. 33: 628-631. doi:10.1053/hupa.2002.124034.
119. van Beers, E.H., and Nederlof, P.M. 2006. Array-CGH and breast cancer. Breast Cancer Res. 8: 210.
120. van Beers, E.H., van Welsem, T., Wessels, L.F., Li, Y., Oldenburg, R.A., Devilee, P., et al. 2005. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. 65: 822-827.
121. van 't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415: 530-536. doi:10.1038/415530a.
122. Waldman, F.M., DeVries, S., Chew, K.L., Moore, D.H., 2nd, Kerlikowske, K., and Ljung, B.M. 2000. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J. Natl. Cancer Inst. 92: 313-320. doi:10.1093/jnci/92.4.313.
123. Waldman, F.M., Hwang, E.S., Etzell, J., Eng, C., DeVries, S., Bennington, J., and Thor, A. 2001. Genomic alterations in tubular breast carcinomas. Hum. Pathol. 32: 222-226. doi:10.1053/hupa.2001.21564.
124. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J., and Qin, J. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14: 927-939.
125. Wang, P., Kim, Y., Pollack, J., Narsimhan, B., and Tibshirani, R. 2005. A method for calling gains and losses in array CGH data. Biostatistics, 6: 45-58. doi:10.1093/biostatistics/kxh017.
126. Weber-Mangal, S., Sinn, H.P., Popp, S., Klaes, R., Emig, R., Bentz, M., et al. 2003. Breast cancer in young women (< or = 35 years): genomic aberrations detected by comparative genomic hybridization. Int. J. Cancer, 107: 583-592. doi:10.1002/ijc.11460.
127. Weiss, M.M., Hermsen, M.A., Meijer, G.A., van Grieken, N.C., Baak, J.P., Kuipers, E.J., and van Diest, P.J. 1999. Comparative genomic hybridisation. Mol. Pathol. 52: 243-251.
128. Weiss, M.M., Kuipers, E.J., Postma, C., Snijders, A.M., Pinkel, D., Meuwissen, S.G., Albertson, D., and Meijer, G.A. 2004. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell. Oncol. 26: 307-317.
129. Wessels, L.F., van Welsem, T., Hart, A.A., van't Veer, L.J., Reinders, M.J., and Nederlof, P.M. 2002. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res. 62: 7110-7117.
130. Willenbrock, H., and Fridlyand, J. 2005. A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics, 21: 4084-4091. doi:10.1093/bioinformatics/bti677.
131. Yang, T.P., Chang, T.Y., Lin, C.H., Hsu, M.T., and Wang, H.W. 2006. ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Bioinformatics, 22: 2697-2698. doi:10.1093/ bioinformatics/bt1457.
132. Ylstra, B., van den Ijssel, P., Carvalho, B., Brakenhoff, R.H., and Meijer, G.A. 2006. BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res. 34: 445-450. doi:10.1093/nar/gkj456.
133. Zhang, J., Feuk, L., Duggan, G.E., Khaja, R., and Scherer, S.W. 2006. Develoment of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet. Genome Res. 115: 205-214. doi:10.1159/000095916.
134. Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., et al. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science, 285: 747-750. doi:10.1126/science.285.5428.747.
135. Zudaire, I., Odero, M.D., Caballero, C., Valenti, C., Martinez-Penuela, J.M., Isola, J., and Calasanz, M.J. 2002. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas. Histopathology, 40: 547-555. doi:10.1046/j.1365-2559. 2002.01413.x.